Improving SH3 domain ligand selectivity using a non-natural scaffold

Chemistry and Biology

Volumn 7, Issue 7, 2000, Pages 463-473

  Nguyen, Jack T ^a   Porter, Margaret ^b   Amoui, Mehran ^b   Miller, W Todd ^b   Zuckermann, Ronald N ^c   Lim, Wendell A ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Kinase activation; Ligand binding; Peptoids; Protein protein interaction; SH3 domains

Indexed keywords

LIGAND; LIGAND BINDING; PEPTOID; PROLINE; SRC HOMOLOGY DOMAIN;

EID: 0033928239     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00130-7     Document Type: Article

References (40)

1. Cohen G.B., Ren R., Baltimore D. Modular binding domains in signal transduction proteins. Cell. 80:1995;237-248.
2. Pawson T. Protein modules and signalling networks. Nature. 373:1995;573-580.
3. Dalgarno D.C., Botfield M.C., Rickles R.J. SH3 domains and drug design. ligands, structure, and biological function Biopolymers. 43:1997;383-400.
4. Smithgall T.E. SH2 and SH3 domains. potential targets for anti-cancer drug design J. Pharmacol. Toxicol. Methods. 34:1995;125-132.
5. Ren R., Mayer B.J., Cicchetti P., Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science. 259:1993;1157-1161.
6. Feng S., Chen J.K., Yu H., Simon J.A., Schreiber S.L. Two binding orientations for peptides to the Src SH3 domain. development of a general model for SH3-ligand interactions Science. 266:1994;1241-1247.
7. Feng S., Kasahara C., Rickles R.J., Schreiber S.L. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl Acad. Sci. USA. 92:1995;12408-12415.
8. Knudsen B.S., Hanafusa H.et al. Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J. 14:1995;2191-2198.
9. Wu X., Kuriyan J.et al. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure. 3:1995;215-226.
10. Lim W.A., Richards F.M., Fox R.O. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature. 372:1994;375-379.
11. Feng S., Kapoor T.M., Shirai F., Combs A.P., Schreiber S.L. Molecular basis for the binding of SH3 ligands with non-peptide elements identified by combinatorial synthesis. Chem. Biol. 3:1996;661-670.
12. Pisabarro M.T., Serrano L. Rational design of specific high-affinity peptide ligands for the Abl- SH3 domain. Biochemistry. 35:1996;10634-10640.
13. Posern G., Feller S.M.et al. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G. Oncogene. 16:1998;1903-1912.
14. Nguyen J.T., Turck C.W., Cohen F.E., Zuckermann R.N., Lim W.A. Exploiting the basis of proline recognition by SH3 and WW domains. design of N-substituted inhibitors Science. 282:1998;2088-2092.
15. Ostergaard S., Holm A. Peptomers. a versatile approach for the preparation of diverse combinatorial peptidomimetic bead libraries Mol. Divers. 3:1997;17-27.
16. Figliozzi G.M., Goldsmith R., Ng S.C., Banville S.C., Zuckermann R.N. Synthesis of N-substituted glycine peptoid libraries. Methods Enzymol. 267:1996;437-447.
17. Simon R.J., Zuckermann R.N.et al. Peptoids: a modular approach to drug discovery. Proc. Natl Acad. Sci. USA. 89:1992;9367-9371.
18. Huang C.Y., Zuckermann R.N.et al. Lipitoids - novel cationic lipids for cellular delivery of plasmid DNA in vitro. Chem. Biol. 5:1998;345-354.
19. Witter D.J., Famiglietti S.J., Cambier J.C., Castelhano A.L. Design and synthesis of SH3 domain binding ligands. modifications of the consensus sequence XPpXP Bioorg. Med. Chem. Lett. 8:1998;3137-3142.
20. Schumacher T.N., Mayr L.M., Minor D.L. Jr., Milhollen M.A., Burgess M.W., Kim P.S. Identification of D-peptide ligands through mirror-image phage display. Science. 271:1996;1854-1857.
21. Rickles R.J., Zoller M.J.et al. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. EMBO J. 13:1994;5598-5604.
22. Rickles R.J., Botfield M.C., Zhou X.M., Henry P.A., Brugge J.S., Zoller M.J. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc. Natl Acad. Sci. USA. 92:1995;10909-10913.
23. Kapoor T.M., Andreotti A.H., Schreiber S.L. Exploring the specificity pockets of two homologous SH3 domains using structure-based, split-pool synthesis and affinity-based selection. J. Am. Chem. Soc. 120:1998;23-29.
24. Morken J.P., Kapoor T.M., Feng S.B., Shirai F., Schreiber S.L. Exploring the leucine-proline binding pocket of the Src SH3 domain using structure-based, split-pool synthesis and affinity-based selection. J. Am. Chem. Soc. 120:1998;30-36.
25. Feller S.M., Knudsen B., Hanafusa H. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13:1994;2341-2351.
26. Ren R., Ye Z.S., Baltimore D. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8:1994;783-795.
27. Feller S.M., Knudsen B.S.et al. Physiological signals and oncogenesis mediated through Crk family adapter proteins. J. Cell Physiol. 177:1998;535-552.
28. Moarefi I., Miller W.T.et al. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 385:1997;650-653.
29. Brown M.T., Cooper J.A. Regulation, substrates and functions of src. Biochim. Biophys. Acta. 1287:1996;121-149.
30. Cooper J.A., Howell B. The when and how of Src regulation. Cell. 73:1993;1051-1054.
31. Sicheri F., Moarefi I., Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature. 385:1997;602-609.
32. Xu W., Harrison S.C., Eck M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 385:1997;595-602.
33. Lee C.H., Saksela K.et al. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14:1995;5006-5015.
34. Lee C.H., Saksela K., Mirza U.A., Chait B.T., Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell. 85:1996;931-942.
35. Kuriyan J., Cowburn D. Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26:1997;259-288.
36. Sparks A.B., Rider J.E., Hoffman N.G., Fowlkes D.M., Quillam L.A., Kay B.K. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. Proc. Natl Acad. Sci. USA. 93:1996;1540-1544.
37. Lim W.A., Fox R.O., Richards F.M. Stability and peptide binding affinity of an SH3 domain from the Caenorhabditis elegans signaling protein Sem-5. Protein Sci. 3:1994;1261-1266.
38. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA. 90:1993;8392-8396.
39. Thomas J.W., Ellis B., Boerner R.J., Knight W.B., White G.C. Jr., Schaller M.D. SH2- and SH3-mediated interactions between focal adhesion kinase and Src. J Biol Chem. 273:1998;577-583.
40. Yu H., Chen J.K., Feng S., Dalgarno D.C., Brauer A.W., Schreiber S.L. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 76:1994;933-945.